The present invention is directed to ACE inhibitor-containing compositions stabilized by the presence of magnesium oxide. Preferably, the ACE inhibitor, quinapril, is protected from certain forms of degradation when prepared in a pharmaceutical composition consisting essentially of magnesium oxide as the stabilizing agent. The presence of magnesium oxide also lends itself to favorable processing conditions during the manufacture of ACE inhibitor-containing compositions, especially processing by wet granulation.

 
Web www.patentalert.com

< Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins

< Hair-growing agent

> Biodegradable microparticles that stabilize and control the release of proteins

> Ganglioside-KLH conjugate vaccines plus QS-21

~ 00247